{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:29:07Z","timestamp":1787765347763,"version":"build-2784847793"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["R01AA023146"],"award-info":[{"award-number":["R01AA023146"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bioelectron Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Over a third of the global population is affected by obesity, fatty liver disease (Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD), and its severe form, MASH (Metabolic Dysfunction-Associated Steatohepatitis), which can ultimately progress to hepatocellular carcinoma (HCC). Recent advancements include therapeutics such as glucagon-like peptide 1 (GLP-1) agonists and neural\/vagal modulation strategies for these disorders. Among the many pathways regulating these conditions, emerging insights into transforming growth factor-\u03b2 (TGF-\u03b2) signaling highlight potential future targets through its role in pathophysiological processes such as adipogenesis, inflammation, and fibrosis. Vagus nerve innervation in the gastrointestinal tract is involved in satiety regulation and energy homeostasis, and vagus nerve stimulation has been applied in weight loss and diabetes. This review explores clinical trials in obesity, novel therapeutic targets, and the role of TGF-\u03b2 signaling and vagus nerve modulation in obesity-related liver diseases and HCC.<\/jats:p>","DOI":"10.1186\/s42234-025-00172-x","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T23:03:36Z","timestamp":1745967816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Recent advances in targeting obesity, with a focus on TGF-\u03b2 signaling and vagus nerve innervation"],"prefix":"10.1186","volume":"11","author":[{"given":"Sahara","family":"John","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishanu","family":"Bhowmick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lopa","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"6","key":"172_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/jamacardio.2018.0016","volume":"3","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG. Management of ventricular arrhythmias and sudden cardiac death risk related to ischemic and nonischemic cardiomyopathy. JAMA Cardiol. 2018;3(6):541\u20132. https:\/\/doi.org\/10.1001\/jamacardio.2018.0016.","journal-title":"JAMA Cardiol"},{"issue":"8","key":"172_CR2","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.2337\/diabetes.49.8.1374","volume":"49","author":"MC Alessi","year":"2000","unstructured":"Alessi MC, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M, Geel O, Juhan-Vague I. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes. 2000;49(8):1374\u201380. https:\/\/doi.org\/10.2337\/diabetes.49.8.1374.","journal-title":"Diabetes"},{"issue":"1","key":"172_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11695-016-2325-7","volume":"27","author":"CM Apovian","year":"2017","unstructured":"Apovian CM, Shah SN, Wolfe BM, Ikramuddin S, Miller CJ, Tweden KS, Billington CJ, Shikora SA. Two-Year outcomes of vagal nerve blocking (vBloc) for the treatment of obesity in the recharge trial. Obes Surg. 2017;27(1):169\u201376. https:\/\/doi.org\/10.1007\/s11695-016-2325-7.","journal-title":"Obes Surg"},{"issue":"5","key":"172_CR4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.cell.2019.10.031","volume":"179","author":"L Bai","year":"2019","unstructured":"Bai L, Mesgarzadeh S, Ramesh KS, Huey EL, Liu Y, Gray LA, Aitken TJ, Chen Y, Beutler LR, Ahn JS, Madisen L, Zeng H, Krasnow MA, Knight ZA. Genetic identification of vagal sensory neurons that control feeding. Cell. 2019;179(5):1129\u2013e11431123. https:\/\/doi.org\/10.1016\/j.cell.2019.10.031.","journal-title":"Cell"},{"issue":"9","key":"172_CR5","doi-asserted-by":"publisher","first-page":"e44813","DOI":"10.1371\/journal.pone.0044813","volume":"7","author":"S Banni","year":"2012","unstructured":"Banni S, Carta G, Murru E, Cordeddu L, Giordano E, Marrosu F, Puligheddu M, Floris G, Asuni GP, Cappai AL, Deriu S, Follesa P. Vagus nerve stimulation reduces body weight and fat mass in rats. PLoS ONE. 2012;7(9):e44813. https:\/\/doi.org\/10.1371\/journal.pone.0044813.","journal-title":"PLoS ONE"},{"issue":"6","key":"172_CR6","doi-asserted-by":"publisher","first-page":"e13854","DOI":"10.1111\/cts.13854","volume":"17","author":"JC Baranda","year":"2024","unstructured":"Baranda JC, Robbrecht D, Sullivan R, Doger B, Santoro A, Barve M, Grob JJ, Bechter O, Vieito M, de Miguel MJ, Schadendorf D, Johnson M, Pouzin C, Cantalloube C, Wang R, Lee J, Chen X, Demers B, Amrate A, Hodi FS. Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFbeta inhibitor, as monotherapy and in combination with Cemiplimab in patients with advanced solid tumors: findings from a phase 1\/1b study. Clin Transl Sci. 2024;17(6):e13854. https:\/\/doi.org\/10.1111\/cts.13854.","journal-title":"Clin Transl Sci"},{"key":"172_CR7","doi-asserted-by":"publisher","unstructured":"Bauer TM, Santoro A, Lin CC, Garrido-Laguna I, Joerger M, Greil R, Spreafico A, Yau T, Goebeler ME, Hutter-Kronke ML, Perotti A, Juif PE, Lu D, Barys L, Cremasco V, Pelletier M, Evans H, Fabre C, Doi T. Phase I\/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-beta monoclonal antibody, NIS793, in combination with Spartalizumab in adult patients with advanced tumors. J Immunother Cancer. 2023;11(11). https:\/\/doi.org\/10.1136\/jitc-2023-007353.","DOI":"10.1136\/jitc-2023-007353"},{"issue":"16","key":"172_CR9","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1001\/archinte.167.16.1720","volume":"167","author":"RP Bogers","year":"2007","unstructured":"Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, van Dam RM, Hu FB, Visscher TL, Menotti A, Thorpe RJ Jr., Jamrozik K, Calling S, Strand BH, Shipley MJ, Investigators B-CC. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167(16):1720\u20138. https:\/\/doi.org\/10.1001\/archinte.167.16.1720.","journal-title":"Arch Intern Med"},{"issue":"10","key":"172_CR10","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.2337\/db15-1723","volume":"65","author":"A Bohm","year":"2016","unstructured":"Bohm A, Hoffmann C, Irmler M, Schneeweiss P, Schnauder G, Sailer C, Schmid V, Hudemann J, Machann J, Schick F, Beckers J, de Hrabe M, Staiger H, Fritsche A, Stefan N, Niess AM, Haring HU, Weigert C. TGF-beta contributes to impaired exercise response by suppression of mitochondrial key regulators in skeletal muscle. Diabetes. 2016;65(10):2849\u201361. https:\/\/doi.org\/10.2337\/db15-1723.","journal-title":"Diabetes"},{"issue":"2","key":"172_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2337\/diabetes.54.2.402","volume":"54","author":"F Bost","year":"2005","unstructured":"Bost F, Aouadi M, Caron L, Even P, Belmonte N, Prot M, Dani C, Hofman P, Pages G, Pouyssegur J, Le Marchand-Brustel Y, Binetruy B. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes. 2005;54(2):402\u201311. https:\/\/doi.org\/10.2337\/diabetes.54.2.402.","journal-title":"Diabetes"},{"issue":"3","key":"172_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1212\/wnl.59.3.463","volume":"59","author":"JG Burneo","year":"2002","unstructured":"Burneo JG, Faught E, Knowlton R, Morawetz R, Kuzniecky R. Weight loss associated with vagus nerve stimulation. Neurology. 2002;59(3):463\u20134. https:\/\/doi.org\/10.1212\/wnl.59.3.463.","journal-title":"Neurology"},{"issue":"3","key":"172_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cell.2019.12.030","volume":"180","author":"MG Campbell","year":"2020","unstructured":"Campbell MG, Cormier A, Ito S, Seed RI, Bondesson AJ, Lou J, Marks JD, Baron JL, Cheng Y, Nishimura SL. Cryo-EM reveals Integrin-Mediated TGF-beta activation without release from latent TGF-beta. Cell. 2020;180(3):490\u2013e501416. https:\/\/doi.org\/10.1016\/j.cell.2019.12.030.","journal-title":"Cell"},{"key":"172_CR14","unstructured":"CDC. (2023). Cancers Associated with Overweight and Obesity Make up 40% of Cancers Diagnosed in the United States. Retrieved November 7 from https:\/\/www.cdc.gov\/cancer\/risk-factors\/obesity.html"},{"issue":"1","key":"172_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1053\/j.gastro.2017.09.007","volume":"154","author":"J Chen","year":"2018","unstructured":"Chen J, Zaidi S, Rao S, Chen JS, Phan L, Farci P, Su X, Shetty K, White J, Zamboni F, Wu X, Rashid A, Pattabiraman N, Mazumder R, Horvath A, Wu RC, Li S, Xiao C, Deng CX, Mishra L. Analysis of genomes and transcriptomes of hepatocellular carcinomas identifies mutations and gene expression changes in the transforming growth Factor-beta pathway. Gastroenterology. 2018;154(1):195\u2013210. https:\/\/doi.org\/10.1053\/j.gastro.2017.09.007.","journal-title":"Gastroenterology"},{"issue":"3","key":"172_CR16","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jcmgh.2021.10.012","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen S, Wu H, Wang Z, Jia M, Guo J, Jin J, Li X, Meng D, Lin L, He AR, Zhou P, Zhi X. Loss of SPTBN1 suppresses autophagy via SETD7-mediated YAP methylation in hepatocellular carcinoma initiation and development. Cell Mol Gastroenterol Hepatol. 2022;13(3):949\u2013e973947. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.10.012.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"172_CR17","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1007\/BF03342141","volume":"12","author":"V Cigaina","year":"2002","unstructured":"Cigaina V. Gastric pacing as therapy for morbid obesity: preliminary results. Obes Surg. 2002;12(Suppl 1):S12\u20136. https:\/\/doi.org\/10.1007\/BF03342141.","journal-title":"Obes Surg"},{"issue":"3","key":"172_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1381\/096089296765556845","volume":"6","author":"VV Cigaina","year":"1996","unstructured":"Cigaina VV, Pinato G, Rigo VV, Bevilacqua M, Ferraro F, Ischia S, Saggioro A. Gastric peristalsis control by mono situ electrical stimulation: a preliminary study. Obes Surg. 1996;6(3):247\u20139. https:\/\/doi.org\/10.1381\/096089296765556845.","journal-title":"Obes Surg"},{"key":"172_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1381\/096089299765553584","volume":"9","author":"VV Cigaina","year":"1999","unstructured":"Cigaina VV, Rigo VV, Greenstein R. Gastric myo-electrical stimulation as therapy for morbid obesity: preliminary results [(abstr 32A)]. Obes Surg. 1999;9:1.","journal-title":"Obes Surg"},{"issue":"12","key":"172_CR20","doi-asserted-by":"publisher","first-page":"e2247186","DOI":"10.1001\/jamanetworkopen.2022.47186","volume":"5","author":"M Cioana","year":"2022","unstructured":"Cioana M, Deng J, Nadarajah A, Hou M, Qiu Y, Chen SSJ, Rivas A, Banfield L, Toor PP, Zhou F, Guven A, Alfaraidi H, Alotaibi A, Thabane L, Samaan MC. The prevalence of obesity among children with type 2 diabetes: A systematic review and Meta-analysis. JAMA Netw Open. 2022;5(12):e2247186. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.47186.","journal-title":"JAMA Netw Open"},{"key":"172_CR21","doi-asserted-by":"publisher","unstructured":"Clifford BL, Sedgeman LR, Williams KJ, Morand P, Cheng A, Jarrett KE, Chan AP, Brearley-Sholto MC, Wahlstrom A, Ashby JW, Barshop W, Wohlschlegel J, Calkin AC, Liu Y, Thorell A, Meikle PJ, Drew BG, Mack JJ, Marschall HU. de Aguiar Vallim, T. Q. FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption. Cell Metab. 2021;33(8):1671\u20131684.e1674. https:\/\/doi.org\/10.1016\/j.cmet.2021.06.012","DOI":"10.1016\/j.cmet.2021.06.012"},{"issue":"6","key":"172_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41551-022-00870-w","volume":"6","author":"V Cotero","year":"2022","unstructured":"Cotero V, Graf J, Miwa H, Hirschstein Z, Qanud K, Huerta TS, Tai N, Ding Y, Jimenez-Cowell K, Tomaio JN, Song W, Devarajan A, Tsaava T, Madhavan R, Wallace K, Loghin E, Morton C, Fan Y, Kao TJ, Puleo C. Stimulation of the hepatoportal nerve plexus with focused ultrasound restores glucose homoeostasis in diabetic mice, rats and swine. Nat Biomed Eng. 2022;6(6):683\u2013705. https:\/\/doi.org\/10.1038\/s41551-022-00870-w.","journal-title":"Nat Biomed Eng"},{"key":"172_CR23","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1381\/096089202762552638","volume":"12","author":"J D\u2019Argent","year":"2002","unstructured":"D\u2019Argent J. Gastric electrical stimulation as therapy of morbid obesity: preliminary results from the French study. Obes Surg. 2002;12:S21\u20135. https:\/\/doi.org\/10.1381\/096089202762552638.","journal-title":"Obes Surg"},{"issue":"3","key":"172_CR24","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s11695-019-04365-7","volume":"30","author":"F Dai","year":"2020","unstructured":"Dai F, Yin J, Chen JDZ. Effects and mechanisms of vagal nerve stimulation on body weight in Diet-Induced obese rats. Obes Surg. 2020;30(3):948\u201356. https:\/\/doi.org\/10.1007\/s11695-019-04365-7.","journal-title":"Obes Surg"},{"issue":"23","key":"172_CR8","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1000367","volume":"363","author":"A de Berrington","year":"2010","unstructured":"de Berrington A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Thun MJ. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1000367.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"172_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF03342136","volume":"14","author":"M De Luca","year":"2004","unstructured":"De Luca M, Segato G, Busetto L, Favretti F, Aigner F, Weiss H, de Gheldere C, Gaggiotti G, Himpens J, Limao J, Scheyer M, Toppino M, Zurmeyer EL, Bottani G, Penthaler H. Progress in implantable gastric stimulation: summary of results of the European multi-center study. Obes Surg. 2004;14(Suppl 1):33\u20139. https:\/\/doi.org\/10.1007\/BF03342136.","journal-title":"Obes Surg"},{"issue":"10","key":"172_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11892-018-1049-6","volume":"18","author":"EM Desjardins","year":"2018","unstructured":"Desjardins EM, Steinberg GR. Emerging role of AMPK in brown and beige adipose tissue (BAT): implications for obesity, insulin resistance, and type 2 diabetes. Curr Diab Rep. 2018;18(10):80. https:\/\/doi.org\/10.1007\/s11892-018-1049-6.","journal-title":"Curr Diab Rep"},{"key":"172_CR27","unstructured":"Diseases N. I. o. D. a. D. a. K. (2021). Overweight & Obesity Statistics. Retrieved September 1 from www.niddk.nih.gov\/health-information\/health-statistics\/overweight-obesity"},{"issue":"15","key":"172_CR28","doi-asserted-by":"publisher","first-page":"19499","DOI":"10.18632\/oncotarget.6967","volume":"7","author":"A Dropmann","year":"2016","unstructured":"Dropmann A, Dediulia T, Breitkopf-Heinlein K, Korhonen H, Janicot M, Weber SN, Thomas M, Piiper A, Bertran E, Fabregat I, Abshagen K, Hess J, Angel P, Coulouarn C, Dooley S, Meindl-Beinker NM. TGF-beta1 and TGF-beta2 abundance in liver diseases of mice and men. Oncotarget. 2016;7(15):19499\u2013518. https:\/\/doi.org\/10.18632\/oncotarget.6967.","journal-title":"Oncotarget"},{"key":"172_CR29","doi-asserted-by":"publisher","first-page":"102872","DOI":"10.1016\/j.amsu.2021.102872","volume":"70","author":"IA Eka Widiastuti","year":"2021","unstructured":"Eka Widiastuti IA, Arsyad A, Idris I, Patellongi I, Kadriyan H, Buanayuda GW, Sari DP, Rosyidi RM. Exercise adaptations and TGF-beta1 levels in recreational cyclists. Ann Med Surg (Lond). 2021;70:102872. https:\/\/doi.org\/10.1016\/j.amsu.2021.102872.","journal-title":"Ann Med Surg (Lond)"},{"issue":"8","key":"172_CR30","doi-asserted-by":"publisher","first-page":"e009288","DOI":"10.1161\/CIRCHEARTFAILURE.122.009288","volume":"15","author":"K Elkholey","year":"2022","unstructured":"Elkholey K, Niewiadomska M, Morris L, Whyte S, Houser J, Humphrey MB, Stavrakis S. Transcutaneous vagus nerve stimulation ameliorates the phenotype of heart failure with preserved ejection fraction through its Anti-Inflammatory effects. Circ Heart Fail. 2022;15(8):e009288. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.122.009288.","journal-title":"Circ Heart Fail"},{"issue":"4","key":"172_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000533358","volume":"64","author":"MG Fadel","year":"2023","unstructured":"Fadel MG, Fehervari M, Das B, Soleimani-Nouri P, Ashrafian H. Vagal nerve therapy in the management of obesity: A systematic review and Meta-Analysis. Eur Surg Res. 2023;64(4):365\u201375. https:\/\/doi.org\/10.1159\/000533358.","journal-title":"Eur Surg Res"},{"issue":"13","key":"172_CR32","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/emboj\/16.13.3912","volume":"16","author":"XH Feng","year":"1997","unstructured":"Feng XH, Derynck R. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity. Embo J. 1997;16(13):3912\u201323. https:\/\/doi.org\/10.1093\/emboj\/16.13.3912.","journal-title":"Embo J"},{"issue":"2","key":"172_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0006-8993(85)91066-2","volume":"341","author":"EA Fox","year":"1985","unstructured":"Fox EA, Powley TL. Longitudinal columnar organization within the dorsal motor nucleus represents separate branches of the abdominal vagus. Brain Res. 1985;341(2):269\u201382. https:\/\/doi.org\/10.1016\/0006-8993(85)91066-2.","journal-title":"Brain Res"},{"issue":"17","key":"172_CR34","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","volume":"385","author":"SM Francque","year":"2021","unstructured":"Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova-Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Group NS. A randomized, controlled trial of the Pan-PPAR agonist lanifibranor in NASH. N Engl J Med. 2021;385(17):1547\u201358. https:\/\/doi.org\/10.1056\/NEJMoa2036205.","journal-title":"N Engl J Med"},{"issue":"6","key":"172_CR35","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa2107519","volume":"385","author":"JP Frias","year":"2021","unstructured":"Frias JP, Davies MJ, Rosenstock J, Perez Manghi FC, Lando F, Bergman L, Liu BK, Cui B, Brown X, K., Investigators S-. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385(6):503\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2107519.","journal-title":"N Engl J Med"},{"issue":"10403","key":"172_CR36","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0140-6736(23)01163-7","volume":"402","author":"JP Frias","year":"2023","unstructured":"Frias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, Mathieu C, Pedersen SD, Davies M. Efficacy and safety of co-administered once-weekly Cagrilintide 2.4\u00a0mg with once-weekly semaglutide 2.4\u00a0mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. Lancet. 2023;402(10403):720\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(23)01163-7.","journal-title":"Lancet"},{"issue":"9774","key":"172_CR37","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","volume":"377","author":"KM Gadde","year":"2011","unstructured":"Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377(9774):1341\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(11)60205-5.","journal-title":"Lancet"},{"issue":"7","key":"172_CR38","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/liv.15578","volume":"43","author":"X Gao","year":"2023","unstructured":"Gao X, Chu Y, Wang W, Li W, Zhang W, Cao J, Fu X, Liu H, Chen D, Fan D, Nie Y. Detrimental role of SIX1 in hepatic lipogenesis and fibrosis of non-alcoholic fatty liver disease. Liver Int. 2023a;43(7):1473\u201385. https:\/\/doi.org\/10.1111\/liv.15578.","journal-title":"Liver Int"},{"issue":"7","key":"172_CR39","doi-asserted-by":"publisher","first-page":"104909","DOI":"10.1016\/j.jbc.2023.104909","volume":"299","author":"Y Gao","year":"2023","unstructured":"Gao Y, Zheng B, Xu S, Zhao Z, Liu W, Wang T, Yuan M, Sun X, Tan Y, Xu Q, Wu X. Mitochondrial folate metabolism-mediated alpha-linolenic acid exhaustion masks liver fibrosis resolution. J Biol Chem. 2023b;299(7):104909. https:\/\/doi.org\/10.1016\/j.jbc.2023.104909.","journal-title":"J Biol Chem"},{"issue":"6","key":"172_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/s0002-9343(97)00254-4","volume":"103","author":"AJ Garber","year":"1997","unstructured":"Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL. Efficacy of Metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med. 1997;103(6):491\u20137. https:\/\/doi.org\/10.1016\/s0002-9343(97)00254-4.","journal-title":"Am J Med"},{"issue":"6","key":"172_CR41","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","volume":"66","author":"D Garcia","year":"2017","unstructured":"Garcia D, Shaw RJ. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell. 2017;66(6):789\u2013800. https:\/\/doi.org\/10.1016\/j.molcel.2017.05.032.","journal-title":"Mol Cell"},{"key":"172_CR42","doi-asserted-by":"publisher","unstructured":"Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham offspring study. Prev Med. 1987;16(2):235\u201351. https:\/\/doi.org\/10.1016\/0091-7435(87)90087-9.","DOI":"10.1016\/0091-7435(87)90087-9"},{"issue":"10402","key":"172_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","volume":"402","author":"WT Garvey","year":"2023","unstructured":"Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM, investigators S-. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023;402(10402):613\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(23)01200-X.","journal-title":"Lancet"},{"issue":"Suppl 3","key":"172_CR44","first-page":"61","volume":"60","author":"K Gil","year":"2009","unstructured":"Gil K, Bugajski A, Kurnik M, Zaraska W, Thor P. Physiological and morphological effects of long-term vagal stimulation in diet induced obesity in rats. J Physiol Pharmacol. 2009;60(Suppl 3):61\u20136. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19996483.","journal-title":"J Physiol Pharmacol"},{"issue":"5","key":"172_CR45","doi-asserted-by":"publisher","first-page":"R1243","DOI":"10.1152\/ajpregu.00679.2005","volume":"291","author":"A Giordano","year":"2006","unstructured":"Giordano A, Song CK, Bowers RR, Ehlen JC, Frontini A, Cinti S, Bartness TJ. White adipose tissue lacks significant vagal innervation and immunohistochemical evidence of parasympathetic innervation. Am J Physiol Regul Integr Comp Physiol. 2006;291(5):R1243\u20131255. https:\/\/doi.org\/10.1152\/ajpregu.00679.2005.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"172_CR46","doi-asserted-by":"publisher","unstructured":"Go YY, Ju WM, Lee CM, Chae SW, Song JJ. Different transcutaneous auricular vagus nerve stimulation parameters modulate the Anti-Inflammatory effects on Lipopolysaccharide-Induced acute inflammation in mice. Biomedicines. 2022;10(2). https:\/\/doi.org\/10.3390\/biomedicines10020247.","DOI":"10.3390\/biomedicines10020247"},{"key":"172_CR47","doi-asserted-by":"publisher","unstructured":"Gomez-Hernandez A, Beneit N, Diaz-Castroverde S, Escribano O. Differential role of adipose tissues in obesity and related metabolic and vascular complications. Int J Endocrinol. 2016;2016(1216783). https:\/\/doi.org\/10.1155\/2016\/1216783.","DOI":"10.1155\/2016\/1216783"},{"issue":"9741","key":"172_CR48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","volume":"376","author":"FL Greenway","year":"2010","unstructured":"Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E, Group C-IS. Effect of Naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595\u2013605. https:\/\/doi.org\/10.1016\/S0140-6736(10)60888-4.","journal-title":"Lancet"},{"issue":"13","key":"172_CR49","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1001\/archinte.163.13.1524","volume":"163","author":"D Gustafson","year":"2003","unstructured":"Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of alzheimer disease. Arch Intern Med. 2003;163(13):1524\u20138. https:\/\/doi.org\/10.1001\/archinte.163.13.1524.","journal-title":"Arch Intern Med"},{"issue":"4","key":"172_CR50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41580-023-00680-1","volume":"25","author":"CE Hagberg","year":"2024","unstructured":"Hagberg CE, Spalding KL. White adipocyte dysfunction and obesity-associated pathologies in humans. Nat Rev Mol Cell Biol. 2024;25(4):270\u201389. https:\/\/doi.org\/10.1038\/s41580-023-00680-1.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"172_CR51","doi-asserted-by":"publisher","first-page":"101336","DOI":"10.1016\/j.molmet.2021.101336","volume":"53","author":"D Halbgebauer","year":"2021","unstructured":"Halbgebauer D, Roos J, Funcke JB, Neubauer H, Hamilton BS, Simon E, Amri EZ, Debatin KM, Wabitsch M, Fischer-Posovszky P, Tews D. Latent TGFbeta-binding proteins regulate UCP1 expression and function via TGFbeta2. Mol Metab. 2021;53:101336. https:\/\/doi.org\/10.1016\/j.molmet.2021.101336.","journal-title":"Mol Metab"},{"issue":"44","key":"172_CR52","doi-asserted-by":"publisher","first-page":"32074","DOI":"10.1074\/jbc.M113.480764","volume":"288","author":"BE Hall","year":"2013","unstructured":"Hall BE, Wankhade UD, Konkel JE, Cherukuri K, Nagineni CN, Flanders KC, Arany PR, Chen W, Rane SG, Kulkarni AB. Transforming growth factor-beta3 (TGF-beta3) knock-in ameliorates inflammation due to TGF-beta1 deficiency while promoting glucose tolerance. J Biol Chem. 2013;288(44):32074\u201392. https:\/\/doi.org\/10.1074\/jbc.M113.480764.","journal-title":"J Biol Chem"},{"issue":"12","key":"172_CR54","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S2468-1253(23)00272-8","volume":"8","author":"SA Harrison","year":"2023","unstructured":"Harrison SA, Frias JP, Neff G, Abrams GA, Lucas KJ, Sanchez W, Gogia S, Sheikh MY, Behling C, Bedossa P, Shao L, Chan D, Fong E, de Temple B, Shringarpure R, Tillman EJ, Rolph T, Cheng A, Yale K, Group HS. Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Gastroenterol Hepatol. 2023a;8(12):1080\u201393. https:\/\/doi.org\/10.1016\/S2468-1253(23)00272-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"172_CR55","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","volume":"29","author":"SA Harrison","year":"2023","unstructured":"Harrison SA, Taub R, Neff GW, Lucas KJ, Labriola D, Moussa SE, Alkhouri N, Bashir MR. Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2023b;29(11):2919\u201328. https:\/\/doi.org\/10.1038\/s41591-023-02603-1.","journal-title":"Nat Med"},{"issue":"6","key":"172_CR53","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Investigators M-N. A phase 3, randomized, controlled trial of Resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390(6):497\u2013509. https:\/\/doi.org\/10.1056\/NEJMoa2309000.","journal-title":"N Engl J Med"},{"key":"172_CR56","doi-asserted-by":"publisher","unstructured":"Hendriks D, Brouwers JF, Hamer K, Geurts MH, Luciana L, Massalini S, Lopez-Iglesias C, Peters PJ, Rodriguez-Colman MJ, Chuva de Sousa Lopes, Artegiani S, B., Clevers H. Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. Nat Biotechnol. 2023;41(11):1567\u20131581. https:\/\/doi.org\/10.1038\/s41587-023-01680-4","DOI":"10.1038\/s41587-023-01680-4"},{"issue":"1","key":"172_CR57","doi-asserted-by":"publisher","first-page":"e2033457","DOI":"10.1001\/jamanetworkopen.2020.33457","volume":"4","author":"SB Heymsfield","year":"2021","unstructured":"Heymsfield SB, Coleman LA, Miller R, Rooks DS, Laurent D, Petricoul O, Praestgaard J, Swan T, Wade T, Perry RG, Goodpaster BH, Roubenoff R. Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: A phase 2 randomized clinical trial. JAMA Netw Open. 2021;4(1):e2033457. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.33457.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"172_CR58","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2337\/db08-0943","volume":"58","author":"DS Hittel","year":"2009","unstructured":"Hittel DS, Berggren JR, Shearer J, Boyle K, Houmard JA. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes. 2009;58(1):30\u20138. https:\/\/doi.org\/10.2337\/db08-0943.","journal-title":"Diabetes"},{"issue":"3","key":"172_CR59","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2337\/diacare.26.3.784","volume":"26","author":"PA Hollander","year":"2003","unstructured":"Hollander PA, Levy P, Fineman MS, Maggs DG, Shen LZ, Strobel SA, Weyer C, Kolterman OG. Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial. Diabetes Care. 2003;26(3):784\u201390. https:\/\/doi.org\/10.2337\/diacare.26.3.784.","journal-title":"Diabetes Care"},{"issue":"5","key":"172_CR60","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95(5):2409\u201315. https:\/\/doi.org\/10.1172\/JCI117936.","journal-title":"J Clin Invest"},{"issue":"7796","key":"172_CR61","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41586-020-2028-z","volume":"578","author":"B Hu","year":"2020","unstructured":"Hu B, Jin C, Zeng X, Resch JM, Jedrychowski MP, Yang Z, Desai BN, Banks AS, Lowell BB, Mathis D, Spiegelman BM. Gammadelta T cells and adipocyte IL-17RC control fat innervation and thermogenesis. Nature. 2020;578(7796):610\u20134. https:\/\/doi.org\/10.1038\/s41586-020-2028-z.","journal-title":"Nature"},{"key":"172_CR62","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1472-6882-14-203","volume":"14","author":"F Huang","year":"2014","unstructured":"Huang F, Dong J, Kong J, Wang H, Meng H, Spaeth RB, Camhi S, Liao X, Li X, Zhai X, Li S, Zhu B, Rong P. Effect of transcutaneous auricular vagus nerve stimulation on impaired glucose tolerance: a pilot randomized study. BMC Complement Altern Med. 2014;14:203. https:\/\/doi.org\/10.1186\/1472-6882-14-203.","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"172_CR63","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1038\/s41598-021-84330-6","volume":"11","author":"TS Huerta","year":"2021","unstructured":"Huerta TS, Devarajan A, Tsaava T, Rishi A, Cotero V, Puleo C, Ashe J, Coleman TR, Chang EH, Tracey KJ, Chavan SS. Targeted peripheral focused ultrasound stimulation attenuates obesity-induced metabolic and inflammatory dysfunctions. Sci Rep. 2021;11(1):5083. https:\/\/doi.org\/10.1038\/s41598-021-84330-6.","journal-title":"Sci Rep"},{"issue":"9","key":"172_CR64","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jama.2014.10540","volume":"312","author":"S Ikramuddin","year":"2014","unstructured":"Ikramuddin S, Blackstone RP, Brancatisano A, Toouli J, Shah SN, Wolfe BM, Fujioka K, Maher JW, Swain J, Que FG, Morton JM, Leslie DB, Brancatisano R, Kow L, O\u2019Rourke RW, Deveney C, Takata M, Miller CJ, Knudson MB, Billington CJ. Effect of reversible intermittent intra-abdominal vagal nerve Blockade on morbid obesity: the recharge randomized clinical trial. JAMA. 2014;312(9):915\u201322. https:\/\/doi.org\/10.1001\/jama.2014.10540.","journal-title":"JAMA"},{"issue":"6651","key":"172_CR65","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/39355","volume":"389","author":"T Imamura","year":"1997","unstructured":"Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K. Smad6 inhibits signalling by the TGF-beta superfamily. Nature. 1997;389(6651):622\u20136. https:\/\/doi.org\/10.1038\/39355.","journal-title":"Nature"},{"key":"172_CR66","unstructured":"Intelligence BH. (2024). Real-World Trends in GLP-1 Treatment Persistence and Prescribing for Weight Management. https:\/\/www.bcbs.com\/media\/pdf\/BHI_Issue_Brief_GLP1_Trends.pdf"},{"issue":"3","key":"172_CR67","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, Investigators S-. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2206038.","journal-title":"N Engl J Med"},{"key":"172_CR68","doi-asserted-by":"publisher","unstructured":"Jastreboff AM, Kaplan LM, Frias JP, Wu Q, Du Y, Gurbuz S, Coskun T, Haupt A, Milicevic Z, Hartman ML. & Retatrutide Phase 2 Obesity Trial, I. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. N Engl J Med. 2023;389(6);514\u2013526. https:\/\/doi.org\/10.1056\/NEJMoa2301972","DOI":"10.1056\/NEJMoa2301972"},{"issue":"1","key":"172_CR69","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11695-016-2278-x","volume":"27","author":"H Johannessen","year":"2017","unstructured":"Johannessen H, Revesz D, Kodama Y, Cassie N, Skibicka KP, Barrett P, Dickson S, Holst J, Rehfeld J, van der Plasse G, Adan R, Kulseng B, Ben-Menachem E, Zhao CM, Chen D. Vagal blocking for obesity control: a possible Mechanism-Of-Action. Obes Surg. 2017;27(1):177\u201385. https:\/\/doi.org\/10.1007\/s11695-016-2278-x.","journal-title":"Obes Surg"},{"issue":"40","key":"172_CR70","doi-asserted-by":"publisher","first-page":"30804","DOI":"10.1074\/jbc.M110.166140","volume":"285","author":"Y Kamiya","year":"2010","unstructured":"Kamiya Y, Miyazono K, Miyazawa K. Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction. J Biol Chem. 2010;285(40):30804\u201313. https:\/\/doi.org\/10.1074\/jbc.M110.166140.","journal-title":"J Biol Chem"},{"issue":"7","key":"172_CR71","doi-asserted-by":"publisher","first-page":"e00056","DOI":"10.14309\/ctg.0000000000000056","volume":"10","author":"RK Kelley","year":"2019","unstructured":"Kelley RK, Gane E, Assenat E, Siebler J, Galle PR, Merle P, Hourmand IO, Cleverly A, Zhao Y, Gueorguieva I, Lahn M, Faivre S, Benhadji KA, Giannelli G. A phase 2 study of Galunisertib (TGF-beta1 receptor type I Inhibitor) and Sorafenib in patients with advanced hepatocellular carcinoma. Clin Transl Gastroenterol. 2019;10(7):e00056. https:\/\/doi.org\/10.14309\/ctg.0000000000000056.","journal-title":"Clin Transl Gastroenterol"},{"key":"172_CR72","unstructured":"Keros. (2024). Keros Therapeutics to Develop KER-065 for the Treatment of Obesity. https:\/\/ir.kerostx.com\/news-releases\/news-release-details\/keros-therapeutics-develop-ker-065-treatment-obesity\/"},{"issue":"8","key":"172_CR73","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.2105\/AJPH.2011.300452","volume":"102","author":"JB Kirby","year":"2012","unstructured":"Kirby JB, Liang L, Chen HJ, Wang Y. Race, place, and obesity: the complex relationships among community Racial\/ethnic composition, individual race\/ethnicity, and obesity in the united States. Am J Public Health. 2012;102(8):1572\u20138. https:\/\/doi.org\/10.2105\/AJPH.2011.300452.","journal-title":"Am J Public Health"},{"key":"172_CR74","doi-asserted-by":"publisher","first-page":"155835","DOI":"10.1016\/j.metabol.2024.155835","volume":"154","author":"M Kokkorakis","year":"2024","unstructured":"Kokkorakis M, Boutari C, Hill MA, Kotsis V, Loomba R, Sanyal AJ, Mantzoros CS. Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges. Metabolism. 2024;154:155835. https:\/\/doi.org\/10.1016\/j.metabol.2024.155835.","journal-title":"Metabolism"},{"key":"172_CR75","doi-asserted-by":"crossref","unstructured":"Kossen Kea. (2019). IDL-2965: a selective, highly potent, clinical- stage integrin antagonist for the treatment of NASH. https:\/\/www.postersessiononline.eu\/173580348_eu\/congresos\/NAFLD2019\/aula\/-P05_17_NAFLD2019.pdf","DOI":"10.1183\/13993003.congress-2019.PA5374"},{"issue":"4","key":"172_CR76","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2337\/db17-0826","volume":"67","author":"A Lawan","year":"2018","unstructured":"Lawan A, Min K, Zhang L, Canfran-Duque A, Jurczak MJ, Camporez JPG, Nie Y, Gavin TP, Shulman GI, Fernandez-Hernando C, Bennett AM. Skeletal Muscle-Specific deletion of MKP-1 reveals a p38 MAPK\/JNK\/Akt signaling node that regulates Obesity-Induced insulin resistance. Diabetes. 2018;67(4):624\u201335. https:\/\/doi.org\/10.2337\/db17-0826.","journal-title":"Diabetes"},{"issue":"6","key":"172_CR77","doi-asserted-by":"publisher","first-page":"R657","DOI":"10.1152\/ajpregu.00345.2011","volume":"302","author":"J Lee","year":"2012","unstructured":"Lee J, Cummings BP, Martin E, Sharp JW, Graham JL, Stanhope KL, Havel PJ, Raybould HE. Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol. 2012;302(6):R657\u2013666. https:\/\/doi.org\/10.1152\/ajpregu.00345.2011.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"172_CR78","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s12276-023-00947-9","volume":"55","author":"SG Lee","year":"2023","unstructured":"Lee SG, Chae J, Woo SM, Seo SU, Kim HJ, Kim SY, Schlaepfer DD, Kim IS, Park HS, Kwon TK, Nam JO. TGFBI remodels adipose metabolism by regulating the Notch-1 signaling pathway. Exp Mol Med. 2023;55(3):520\u201331. https:\/\/doi.org\/10.1038\/s12276-023-00947-9.","journal-title":"Exp Mol Med"},{"key":"172_CR80","doi-asserted-by":"publisher","first-page":"33469","DOI":"10.1038\/srep33469","volume":"6","author":"N Li","year":"2016","unstructured":"Li N, Yang Y, He K, Zhang F, Zhao L, Zhou W, Yuan J, Liang W, Fang X. Single-Molecule imaging reveals the activation dynamics of intracellular protein Smad3 on cell membrane. Sci Rep. 2016;6:33469. https:\/\/doi.org\/10.1038\/srep33469.","journal-title":"Sci Rep"},{"issue":"11","key":"172_CR79","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1016\/j.bbadis.2017.08.012","volume":"1863","author":"J Li","year":"2017","unstructured":"Li J, Chen C, Li Y, Matye DJ, Wang Y, Ding WX, Li T. Inhibition of insulin\/PI3K\/AKT signaling decreases adipose sortilin 1 in mice and 3T3-L1 adipocytes. Biochim Biophys Acta Mol Basis Dis. 2017;1863(11):2924\u201333. https:\/\/doi.org\/10.1016\/j.bbadis.2017.08.012.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"172_CR81","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/HEP.0000000000001054","volume":"81","author":"HY Lim","year":"2025","unstructured":"Lim HY, Heo J, Peguero JA, Ryoo BY, Decaens T, Barlesi F, Moehler MH, Jehl G, Eggleton SP, Bajars M, Gulley JL. Efficacy and safety of bintrafusp Alfa in 2 phase I expansion cohorts with advanced HCC. Hepatology. 2025;81(1):32\u201343. https:\/\/doi.org\/10.1097\/HEP.0000000000001054.","journal-title":"Hepatology"},{"issue":"18","key":"172_CR82","doi-asserted-by":"publisher","first-page":"12246","DOI":"10.1074\/jbc.M805379200","volume":"284","author":"HM Lin","year":"2009","unstructured":"Lin HM, Lee JH, Yadav H, Kamaraju AK, Liu E, Zhigang D, Vieira A, Kim SJ, Collins H, Matschinsky F, Harlan DM, Roberts AB, Rane SG. Transforming growth factor-beta\/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J Biol Chem. 2009;284(18):12246\u201357. https:\/\/doi.org\/10.1074\/jbc.M805379200.","journal-title":"J Biol Chem"},{"issue":"9","key":"172_CR83","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.7150\/thno.49819","volume":"11","author":"L Lin","year":"2021","unstructured":"Lin L, Chen S, Wang H, Gao B, Kallakury B, Bhuvaneshwar K, Cahn K, Gusev Y, Wang X, Wu Y, Marshall JL, Zhi X, He AR. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma. Theranostics. 2021;11(9):4232\u201350. https:\/\/doi.org\/10.7150\/thno.49819.","journal-title":"Theranostics"},{"key":"172_CR84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.matbio.2022.01.005","volume":"107","author":"MP Lockhart-Cairns","year":"2022","unstructured":"Lockhart-Cairns MP, Cain SA, Dajani R, Steer R, Thomson J, Alanazi YF, Kielty CM, Baldock C. Latent TGFbeta complexes are transglutaminase cross-linked to fibrillin to facilitate TGFbeta activation. Matrix Biol. 2022;107:24\u201339. https:\/\/doi.org\/10.1016\/j.matbio.2022.01.005.","journal-title":"Matrix Biol"},{"key":"172_CR85","doi-asserted-by":"publisher","first-page":"101343","DOI":"10.1016\/j.molmet.2021.101343","volume":"54","author":"JZ Longenecker","year":"2021","unstructured":"Longenecker JZ, Petrosino JM, Martens CR, Hinger SA, Royer CJ, Dorn LE, Branch DA, Serrano J, Stanford KI, Kyriazis GA, Baskin KK, Accornero F. Cardiac-derived TGF-beta1 confers resistance to diet-induced obesity through the regulation of adipocyte size and function. Mol Metab. 2021;54:101343. https:\/\/doi.org\/10.1016\/j.molmet.2021.101343.","journal-title":"Mol Metab"},{"issue":"4","key":"172_CR86","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa2401943","volume":"391","author":"R Loomba","year":"2024","unstructured":"Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, Bugianesi E, Yoneda M, Behling C, Cummings OW, Tang Y, Brouwers B, Robins DA, Nikooie A, Bunck MC, Haupt A, Sanyal AJ, Investigators S-N. Tirzepatide for metabolic Dysfunction-Associated steatohepatitis with liver fibrosis. N Engl J Med. 2024;391(4):299\u2013310. https:\/\/doi.org\/10.1056\/NEJMoa2401943.","journal-title":"N Engl J Med"},{"issue":"1","key":"172_CR87","doi-asserted-by":"publisher","first-page":"10394","DOI":"10.1038\/s41598-021-89465-0","volume":"11","author":"H Loper","year":"2021","unstructured":"Loper H, Leinen M, Bassoff L, Sample J, Romero-Ortega M, Gustafson KJ, Taylor DM, Schiefer MA. Both high fat and high carbohydrate diets impair vagus nerve signaling of satiety. Sci Rep. 2021;11(1):10394. https:\/\/doi.org\/10.1038\/s41598-021-89465-0.","journal-title":"Sci Rep"},{"issue":"5","key":"172_CR88","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/FJC.0000000000000062","volume":"63","author":"Y Lu","year":"2014","unstructured":"Lu Y, Liu JJ, Bi XY, Yu XJ, Kong SS, Qin FF, Zhou J, Zang WJ. Pyridostigmine ameliorates cardiac remodeling induced by myocardial infarction via Inhibition of the transforming growth factor-beta1\/TGF-beta1-activated kinase pathway. J Cardiovasc Pharmacol. 2014;63(5):412\u201320. https:\/\/doi.org\/10.1097\/FJC.0000000000000062.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"172_CR89","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2337\/db22-0444","volume":"72","author":"D Luan","year":"2023","unstructured":"Luan D, Dadpey B, Zaid J, Bridge-Comer PE, DeLuca JH, Xia W, Castle J, Reilly SM. Adipocyte-Secreted IL-6 sensitizes macrophages to IL-4 signaling. Diabetes. 2023;72(3):367\u201374. https:\/\/doi.org\/10.2337\/db22-0444.","journal-title":"Diabetes"},{"issue":"1","key":"172_CR90","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2014.03.031","volume":"20","author":"PB Martinez de Morentin","year":"2014","unstructured":"Martinez de Morentin PB, Gonzalez-Garcia I, Martins L, Lage R, Fernandez-Mallo D, Martinez-Sanchez N, Ruiz-Pino F, Liu J, Morgan DA, Pinilla L, Gallego R, Saha AK, Kalsbeek A, Fliers E, Bisschop PH, Dieguez C, Nogueiras R, Rahmouni K, Tena-Sempere M, Lopez M. Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK. Cell Metab. 2014;20(1):41\u201353. https:\/\/doi.org\/10.1016\/j.cmet.2014.03.031.","journal-title":"Cell Metab"},{"issue":"10","key":"172_CR91","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massague","year":"2012","unstructured":"Massague J. TGFbeta signalling in context. Nat Rev Mol Cell Biol. 2012;13(10):616\u201330. https:\/\/doi.org\/10.1038\/nrm3434.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"19","key":"172_CR92","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","volume":"186","author":"J Massague","year":"2023","unstructured":"Massague J, Sheppard D. TGF-beta signaling in health and disease. Cell. 2023;186(19):4007\u201337. https:\/\/doi.org\/10.1016\/j.cell.2023.07.036.","journal-title":"Cell"},{"issue":"23","key":"172_CR93","doi-asserted-by":"publisher","first-page":"12457","DOI":"10.1073\/pnas.94.23.12457","volume":"94","author":"AC McPherron","year":"1997","unstructured":"McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A. 1997;94(23):12457\u201361. https:\/\/doi.org\/10.1073\/pnas.94.23.12457.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"172_CR94","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.metabol.2018.04.005","volume":"85","author":"NF Mendes","year":"2018","unstructured":"Mendes NF, Gaspar JM, Lima-Junior JC, Donato J Jr., Velloso LA, Araujo EP. TGF-beta1 down-regulation in the mediobasal hypothalamus attenuates hypothalamic inflammation and protects against diet-induced obesity. Metabolism. 2018;85:171\u201382. https:\/\/doi.org\/10.1016\/j.metabol.2018.04.005.","journal-title":"Metabolism"},{"issue":"1\u20132","key":"172_CR95","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cytogfr.2005.09.001","volume":"17","author":"L Mishra","year":"2006","unstructured":"Mishra L, Marshall B. Adaptor proteins and ubiquinators in TGF-beta signaling. Cytokine Growth Factor Rev. 2006;17(1\u20132):75\u201387. https:\/\/doi.org\/10.1016\/j.cytogfr.2005.09.001.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"172_CR96","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/toxsci\/kfaa024","volume":"175","author":"MS Mitra","year":"2020","unstructured":"Mitra MS, Lancaster K, Adedeji AO, Palanisamy GS, Dave RA, Zhong F, Holdren MS, Turley SJ, Liang WC, Wu Y, Meng YG, Vernes JM, Schutten MM. A potent Pan-TGFbeta neutralizing monoclonal antibody elicits cardiovascular toxicity in mice and cynomolgus monkeys. Toxicol Sci. 2020;175(1):24\u201334. https:\/\/doi.org\/10.1093\/toxsci\/kfaa024.","journal-title":"Toxicol Sci"},{"issue":"8","key":"172_CR97","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/j.celrep.2016.07.048","volume":"16","author":"S Modica","year":"2016","unstructured":"Modica S, Straub LG, Balaz M, Sun W, Varga L, Stefanicka P, Profant M, Simon E, Neubauer H, Ukropcova B, Ukropec J, Wolfrum C. Bmp4 promotes a brown to White-like adipocyte shift. Cell Rep. 2016;16(8):2243\u201358. https:\/\/doi.org\/10.1016\/j.celrep.2016.07.048.","journal-title":"Cell Rep"},{"issue":"8","key":"172_CR98","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13059-014-0428-9","volume":"15","author":"LD Nadauld","year":"2014","unstructured":"Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, Chen H, Flaherty P, Ootani A, Zhang NR, Ford JM, Kuo CJ, Ji HP. Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. Genome Biol. 2014;15(8):428. https:\/\/doi.org\/10.1186\/s13059-014-0428-9.","journal-title":"Genome Biol"},{"key":"172_CR99","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.autneu.2014.01.009","volume":"183","author":"I Naggar","year":"2014","unstructured":"Naggar I, Nakase K, Lazar J, Salciccioli L, Selesnick I, Stewart M. Vagal control of cardiac electrical activity and wall motion during ventricular fibrillation in large animals. Auton Neurosci. 2014;183:12\u201322. https:\/\/doi.org\/10.1016\/j.autneu.2014.01.009.","journal-title":"Auton Neurosci"},{"key":"172_CR100","doi-asserted-by":"publisher","first-page":"101880","DOI":"10.1016\/j.molmet.2024.101880","volume":"80","author":"E Nunn","year":"2024","unstructured":"Nunn E, Jaiswal N, Gavin M, Uehara K, Stefkovich M, Drareni K, Calhoun R, Lee M, Holman CD, Baur JA, Seale P, Titchenell PM. Antibody Blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism. Mol Metab. 2024;80:101880. https:\/\/doi.org\/10.1016\/j.molmet.2024.101880.","journal-title":"Mol Metab"},{"issue":"4","key":"172_CR101","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2967\/jnumed.117.197053","volume":"59","author":"P Orthey","year":"2018","unstructured":"Orthey P, Yu D, Van Natta ML, Ramsey FV, Diaz JR, Bennett PA, Iagaru AH, Fragomeni RS, McCallum RW, Sarosiek I, Hasler WL, Farrugia G, Grover M, Koch KL, Nguyen L, Snape WJ, Abell TL, Pasricha PJ, Tonascia J, Consortium NIHG. Intragastric meal distribution during gastric emptying scintigraphy for assessment of fundic accommodation: correlation with symptoms of gastroparesis. J Nucl Med. 2018;59(4):691\u20137. https:\/\/doi.org\/10.2967\/jnumed.117.197053.","journal-title":"J Nucl Med"},{"issue":"11","key":"172_CR102","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1056\/NEJMoa1113966","volume":"367","author":"A Pal","year":"2012","unstructured":"Pal A, Barber TM, Van de Bunt M, Rudge SA, Zhang Q, Lachlan KL, Cooper NS, Linden H, Levy JC, Wakelam MJ, Walker L, Karpe F, Gloyn AL. PTEN mutations as a cause of constitutive insulin sensitivity and obesity. N Engl J Med. 2012;367(11):1002\u201311. https:\/\/doi.org\/10.1056\/NEJMoa1113966.","journal-title":"N Engl J Med"},{"issue":"9","key":"172_CR103","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2337\/db23-0180","volume":"72","author":"Q Pan","year":"2023","unstructured":"Pan Q, Ai W, Chen Y, Kim DM, Shen Z, Yang W, Jiang W, Sun Y, Safe S, Guo S. Reciprocal regulation of hepatic TGF-beta1 and Foxo1 controls gluconeogenesis and energy expenditure. Diabetes. 2023;72(9):1193\u2013206. https:\/\/doi.org\/10.2337\/db23-0180.","journal-title":"Diabetes"},{"issue":"11","key":"172_CR104","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1038\/sj.ijo.0803666","volume":"31","author":"JV Pardo","year":"2007","unstructured":"Pardo JV, Sheikh SA, Kuskowski MA, Surerus-Johnson C, Hagen MC, Lee JT, Rittberg BR, Adson DE. Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation. Int J Obes (Lond). 2007;31(11):1756\u20139. https:\/\/doi.org\/10.1038\/sj.ijo.0803666.","journal-title":"Int J Obes (Lond)"},{"key":"172_CR178","doi-asserted-by":"crossref","unstructured":"Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol. 2012;8(12):743-754. https:\/\/doi.org\/10.1038\/nrendo.2012.189.","DOI":"10.1038\/nrendo.2012.189"},{"issue":"23","key":"172_CR105","doi-asserted-by":"publisher","first-page":"11520","DOI":"10.18632\/aging.102552","volume":"11","author":"Q Peng","year":"2019","unstructured":"Peng Q, Chen B, Wang H, Zhu Y, Wu J, Luo Y, Zuo G, Luo J, Zhou L, Shi Q, Weng Y, Huang A, He TC, Fan J. Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes. Aging. 2019;11(23):11520\u201340. https:\/\/doi.org\/10.18632\/aging.102552.","journal-title":"Aging"},{"issue":"22","key":"172_CR106","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1091\/mbc.E09-12-1019","volume":"21","author":"SG Penheiter","year":"2010","unstructured":"Penheiter SG, Singh RD, Repellin CE, Wilkes MC, Edens M, Howe PH, Pagano RE, Leof EB. Type II transforming growth factor-beta receptor recycling is dependent upon the clathrin adaptor protein Dab2. Mol Biol Cell. 2010;21(22):4009\u201319. https:\/\/doi.org\/10.1091\/mbc.E09-12-1019.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"172_CR107","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.celrep.2018.09.069","volume":"25","author":"P Petrus","year":"2018","unstructured":"Petrus P, Mejhert N, Corrales P, Lecoutre S, Li Q, Maldonado E, Kulyte A, Lopez Y, Campbell M, Acosta JR, Laurencikiene J, Douagi I, Gao H, Martinez-Alvarez C, Heden P, Spalding KL, Vidal-Puig A, Medina-Gomez G, Arner P, Ryden M. Transforming growth Factor-beta3 regulates adipocyte number in subcutaneous white adipose tissue. Cell Rep. 2018;25(3):551\u2013e560555. https:\/\/doi.org\/10.1016\/j.celrep.2018.09.069.","journal-title":"Cell Rep"},{"issue":"1","key":"172_CR108","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Ortiz V, Jensen R, Wilding CB, Obesity JP, S., Prediabetes NN S. G. A randomized, controlled trial of 3.0\u00a0mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1411892.","journal-title":"N Engl J Med"},{"issue":"5","key":"172_CR109","doi-asserted-by":"publisher","first-page":"G576","DOI":"10.1152\/ajpgi.00214.2021","volume":"321","author":"TL Powley","year":"2021","unstructured":"Powley TL. Brain-gut communication: vagovagal reflexes interconnect the two brains. Am J Physiol Gastrointest Liver Physiol. 2021;321(5):G576\u201387. https:\/\/doi.org\/10.1152\/ajpgi.00214.2021.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"172_CR110","doi-asserted-by":"publisher","unstructured":"Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934\u201342. https:\/\/doi.org\/10.1001\/jama.2014.10706.","DOI":"10.1001\/jama.2014.10706"},{"issue":"9","key":"172_CR111","doi-asserted-by":"publisher","first-page":"E798","DOI":"10.1073\/pnas.1215236110","volume":"110","author":"SW Qian","year":"2013","unstructured":"Qian SW, Tang Y, Li X, Liu Y, Zhang YY, Huang HY, Xue RD, Yu HY, Guo L, Gao HD, Liu Y, Sun X, Li YM, Jia WP, Tang QQ. BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis. Proc Natl Acad Sci U S A. 2013;110(9):E798\u2013807. https:\/\/doi.org\/10.1073\/pnas.1215236110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"172_CR112","doi-asserted-by":"publisher","unstructured":"Qin G, Ma J, Huang Q, Yin H, Han J, Li M, Deng Y, Wang B, Hassan W, Shang J. Isoquercetin improves hepatic lipid accumulation by activating AMPK pathway and suppressing TGF-beta signaling on an HFD-Induced nonalcoholic fatty liver disease rat model. Int J Mol Sci. 2018;19(12). https:\/\/doi.org\/10.3390\/ijms19124126.","DOI":"10.3390\/ijms19124126"},{"issue":"1","key":"172_CR113","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, Tan DJH, Tang ASP, Tay P, Xiao J, Yong JN, Zeng RW, Chew NWS, Nah B, Kulkarni A, Siddiqui MS, Dan YY, Wong VW, Sanyal AJ, Ng CH. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(22)00317-X.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"624","key":"172_CR114","doi-asserted-by":"publisher","first-page":"eabk2267","DOI":"10.1126\/scitranslmed.abk2267","volume":"13","author":"S Rao","year":"2021","unstructured":"Rao S, Yang X, Ohshiro K, Zaidi S, Wang Z, Shetty K, Xiang X, Hassan MI, Mohammad T, Latham PS, Nguyen BN, Wong L, Yu H, Al-Abed Y, Mishra B, Vacca M, Guenigault G, Allison MED, Vidal-Puig A, Mishra L. beta2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development. Sci Transl Med. 2021;13(624):eabk2267. https:\/\/doi.org\/10.1126\/scitranslmed.abk2267.","journal-title":"Sci Transl Med"},{"issue":"20","key":"172_CR115","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.1128\/MCB.23.20.7230-7242.2003","volume":"23","author":"A Rebbapragada","year":"2003","unstructured":"Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Attisano L. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol. 2003;23(20):7230\u201342. https:\/\/doi.org\/10.1128\/MCB.23.20.7230-7242.2003.","journal-title":"Mol Cell Biol"},{"issue":"10401","key":"172_CR116","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0140-6736(23)01053-X","volume":"402","author":"J Rosenstock","year":"2023","unstructured":"Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. Lancet. 2023;402(10401):529\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(23)01053-X.","journal-title":"Lancet"},{"issue":"6","key":"172_CR117","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S2213-8587(24)00087-1","volume":"12","author":"CL Roth","year":"2024","unstructured":"Roth CL, Scimia C, Shoemaker AH, Gottschalk M, Miller J, Yuan G, Malhotra S, Abuzzahab MJ. Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial. Lancet Diabetes Endocrinol. 2024;12(6):380\u20139. https:\/\/doi.org\/10.1016\/S2213-8587(24)00087-1.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"172_CR118","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ciresp.2014.06.010","volume":"93","author":"J Ruiz-Tovar","year":"2015","unstructured":"Ruiz-Tovar J, Llavero C, Ortega I, Diez M, Zubiaga L, Calpena R. Percutaneous electric neurostimulation of dermatome T7 improves glycemic profile in obese and type 2 diabetic patients. A randomized clinical study. Cir Esp. 2015;93(7):460\u20135. https:\/\/doi.org\/10.1016\/j.ciresp.2014.06.010.","journal-title":"Cir Esp"},{"key":"172_CR119","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbrc.2022.05.100","volume":"618","author":"M Sakurai","year":"2022","unstructured":"Sakurai M, Weber P, Wolff G, Wieder A, Szendroedi J, Herzig S, Ustunel E, B. TSC22D4 promotes TGFbeta1-induced activation of hepatic stellate cells. Biochem Biophys Res Commun. 2022;618:46\u201353. https:\/\/doi.org\/10.1016\/j.bbrc.2022.05.100.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"172_CR120","doi-asserted-by":"publisher","first-page":"101235","DOI":"10.1016\/j.jbc.2021.101235","volume":"297","author":"M Saleh","year":"2021","unstructured":"Saleh M, Mohamed NA, Sehrawat A, Zhang T, Thomas M, Wang Y, Kalsi R, Molitoris J, Prasadan K, Gittes GK. beta-cell Smad2 null mice have improved beta-cell function and are protected from diet-induced hyperglycemia. J Biol Chem. 2021;297(5):101235. https:\/\/doi.org\/10.1016\/j.jbc.2021.101235.","journal-title":"J Biol Chem"},{"issue":"1","key":"172_CR121","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF03401666","volume":"3","author":"F Samad","year":"1997","unstructured":"Samad F, Yamamoto K, Pandey M, Loskutoff DJ. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med. 1997;3(1):37\u201348. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9132278.","journal-title":"Mol Med"},{"issue":"4","key":"172_CR122","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1177\/193229680900300445","volume":"3","author":"CP Sanmiguel","year":"2009","unstructured":"Sanmiguel CP, Conklin JL, Cunneen SA, Barnett P, Phillips EH, Kipnes M, Pilcher J, Soffer EE. Gastric electrical stimulation with the TANTALUS system in obese type 2 diabetes patients: effect on weight and glycemic control. J Diabetes Sci Technol. 2009;3(4):964\u201370. https:\/\/doi.org\/10.1177\/193229680900300445.","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"172_CR123","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa2401755","volume":"391","author":"AJ Sanyal","year":"2024","unstructured":"Sanyal AJ, Bedossa P, Fraessdorf M, Neff GW, Lawitz E, Bugianesi E, Anstee QM, Hussain SA, Newsome PN, Ratziu V, Hosseini-Tabatabaei A, Schattenberg JM, Noureddin M, Alkhouri N, Younes R, Trial I. A phase 2 randomized trial of survodutide in MASH and fibrosis. N Engl J Med. 2024;391(4):311\u20139. https:\/\/doi.org\/10.1056\/NEJMoa2401755.","journal-title":"N Engl J Med"},{"issue":"11","key":"172_CR124","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s11695-012-0751-8","volume":"22","author":"MG Sarr","year":"2012","unstructured":"Sarr MG, Billington CJ, Brancatisano R, Brancatisano A, Toouli J, Kow L, Nguyen NT, Blackstone R, Maher JW, Shikora S, Reeds DN, Eagon JC, Wolfe BM, O\u2019Rourke RW, Fujioka K, Takata M, Swain JM, Morton JM, Ikramuddin S, Group ES. The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal Blockade to induce weight loss in morbid obesity. Obes Surg. 2012;22(11):1771\u201382. https:\/\/doi.org\/10.1007\/s11695-012-0751-8.","journal-title":"Obes Surg"},{"key":"172_CR125","doi-asserted-by":"publisher","first-page":"111934","DOI":"10.1016\/j.biopha.2021.111934","volume":"141","author":"MS Savova","year":"2021","unstructured":"Savova MS, Vasileva LV, Mladenova SG, Amirova KM, Ferrante C, Orlando G, Wabitsch M, Georgiev MI. Ziziphus Jujuba mill. Leaf extract restrains adipogenesis by targeting PI3K\/AKT signaling pathway. Biomed Pharmacother. 2021;141:111934. https:\/\/doi.org\/10.1016\/j.biopha.2021.111934.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"172_CR126","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41419-018-0489-x","volume":"9","author":"HA Seong","year":"2018","unstructured":"Seong HA, Manoharan R, Ha H. Smad proteins differentially regulate obesity-induced glucose and lipid abnormalities and inflammation via class-specific control of AMPK-related kinase MPK38\/MELK activity. Cell Death Dis. 2018;9(5):471. https:\/\/doi.org\/10.1038\/s41419-018-0489-x.","journal-title":"Cell Death Dis"},{"issue":"1","key":"172_CR128","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.soard.2008.09.012","volume":"5","author":"SA Shikora","year":"2009","unstructured":"Shikora SA, Bergenstal R, Bessler M, Brody F, Foster G, Frank A, Gold M, Klein S, Kushner R, Sarwer DB. Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. Surg Obes Relat Dis. 2009;5(1):31\u20137. https:\/\/doi.org\/10.1016\/j.soard.2008.09.012.","journal-title":"Surg Obes Relat Dis"},{"key":"172_CR127","doi-asserted-by":"publisher","unstructured":"Shikora S, Toouli J, Herrera MF, Kulseng B, Zulewski H, Brancatisano R, Kow L, Pantoja JP, Johnsen G, Brancatisano A, Tweden KS, Knudson MB, Billington CJ. Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. J Obes 2013;2013:245683. https:\/\/doi.org\/10.1155\/2013\/245683","DOI":"10.1155\/2013\/245683"},{"key":"172_CR129","doi-asserted-by":"publisher","unstructured":"Shikora SA, Wolfe BM, Apovian CM, Anvari M, Sarwer DB, Gibbons RD, Ikramuddin S, Miller CJ, Knudson MB, Tweden KS, Sarr MG, Billington CJ. Sustained weight loss with vagal nerve Blockade but not with Sham: 18-Month results of the recharge trial. J Obes. 2015;2015(365604). https:\/\/doi.org\/10.1155\/2015\/365604.","DOI":"10.1155\/2015\/365604"},{"issue":"10","key":"172_CR130","doi-asserted-by":"publisher","first-page":"e13911","DOI":"10.1111\/nmo.13911","volume":"32","author":"V Sinniger","year":"2020","unstructured":"Sinniger V, Pellissier S, Fauvelle F, Trocme C, Hoffmann D, Vercueil L, Cracowski JL, David O, Bonaz B. A 12-month pilot study outcomes of vagus nerve stimulation in Crohn\u2019s disease. Neurogastroenterol Motil. 2020;32(10):e13911. https:\/\/doi.org\/10.1111\/nmo.13911.","journal-title":"Neurogastroenterol Motil"},{"issue":"8","key":"172_CR131","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cmet.2023.06.016","volume":"35","author":"KA Sjoberg","year":"2023","unstructured":"Sjoberg KA, Sigvardsen CM, Alvarado-Diaz A, Andersen NR, Larance M, Seeley RJ, Schjerling P, Knudsen JG, Katzilieris-Petras G, Clemmensen C, Jorgensen SB, De Bock K, Richter EA. GDF15 increases insulin action in the liver and adipose tissue via a beta-adrenergic receptor-mediated mechanism. Cell Metab. 2023;35(8):1327\u2013e13401325. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.016.","journal-title":"Cell Metab"},{"issue":"9123","key":"172_CR132","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s0140-6736(97)11509-4","volume":"352","author":"L Sjostrom","year":"1998","unstructured":"Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M. Randomised placebo-controlled trial of Orlistat for weight loss and prevention of weight regain in obese patients. European multicentre Orlistat study group. Lancet. 1998;352(9123):167\u201372. https:\/\/doi.org\/10.1016\/s0140-6736(97)11509-4.","journal-title":"Lancet"},{"issue":"1","key":"172_CR133","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41573-021-00284-4","volume":"21","author":"RJ Slack","year":"2022","unstructured":"Slack RJ, Macdonald SJF, Roper JA, Jenkins RG, Hatley RJD. Emerging therapeutic opportunities for integrin inhibitors. Nat Rev Drug Discov. 2022;21(1):60\u201378. https:\/\/doi.org\/10.1038\/s41573-021-00284-4.","journal-title":"Nat Rev Drug Discov"},{"key":"172_CR134","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae550","author":"WB Smith","year":"2024","unstructured":"Smith WB, Nguyen D, Clough T, Schofield J, Kagan MR, Kompa J, He Y, Maratos-Flier E, Jamontt J, Vong L, Schwartzkopf CD, Layne JD, Usera AR, O\u2019Donnell CJ, Heldwein KA, Streeper RS, Goldfine AB. A growth-differentiation factor 15 receptor agonist in randomized placebo-controlled trials in healthy or obese persons. J Clin Endocrinol Metab. 2024. https:\/\/doi.org\/10.1210\/clinem\/dgae550.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"172_CR135","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11695-012-0857-z","volume":"23","author":"J Sobocki","year":"2013","unstructured":"Sobocki J, Herman RM, Fraczek M. Occipital C1-C2 neuromodulation decreases body mass and fat stores and modifies activity of the autonomic nervous system in morbidly obese patients\u2013a pilot study. Obes Surg. 2013;23(5):693\u20137. https:\/\/doi.org\/10.1007\/s11695-012-0857-z.","journal-title":"Obes Surg"},{"issue":"2","key":"172_CR136","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.molmet.2016.12.001","volume":"6","author":"G Solinas","year":"2017","unstructured":"Solinas G, Becattini B. JNK at the crossroad of obesity, insulin resistance, and cell stress response. Mol Metab. 2017;6(2):174\u201384. https:\/\/doi.org\/10.1016\/j.molmet.2016.12.001.","journal-title":"Mol Metab"},{"issue":"1","key":"172_CR137","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1507\/endocrj.k10e-248","volume":"58","author":"JW Son","year":"2011","unstructured":"Son JW, Kim MK, Park YM, Baek KH, Yoo SJ, Song KH, Son HS, Yoon KH, Lee WC, Cha BY, Son HY, Kwon HS. Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals. Endocr J. 2011;58(1):39\u201346. https:\/\/doi.org\/10.1507\/endocrj.k10e-248.","journal-title":"Endocr J"},{"key":"172_CR138","first-page":"1","volume":"4","author":"AJ Stauber","year":"2014","unstructured":"Stauber AJ, Credille KM, Truex LL, Ehlhardt WJ, Young JK. Nonclinical safety evaluation of a transforming growth factor \u0392 receptor I kinase inhibitor in Fischer 344 rats and beagle dogs. J Clin Toxicol. 2014;4:1\u201310.","journal-title":"J Clin Toxicol"},{"issue":"2","key":"172_CR139","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ki.2015.121","volume":"88","author":"YB Sun","year":"2015","unstructured":"Sun YB, Qu X, Howard V, Dai L, Jiang X, Ren Y, Fu P, Puelles VG, Nikolic-Paterson DJ, Caruana G, Bertram JF, Sleeman MW, Li J. Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance. Kidney Int. 2015;88(2):286\u201398. https:\/\/doi.org\/10.1038\/ki.2015.121.","journal-title":"Kidney Int"},{"issue":"2","key":"172_CR140","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s42255-018-0030-7","volume":"1","author":"H Takahashi","year":"2019","unstructured":"Takahashi H, Alves CRR, Stanford KI, Middelbeek RJW, Nigro P, Ryan RE, Xue R, Sakaguchi M, Lynes MD, So K, Mul JD, Lee MY, Balan E, Pan H, Dreyfuss JM, Hirshman MF, Azhar M, Hannukainen JC, Nuutila P, Goodyear LJ. TGF-beta2 is an exercise-induced adipokine that regulates glucose and fatty acid metabolism. Nat Metab. 2019;1(2):291\u2013303. https:\/\/doi.org\/10.1038\/s42255-018-0030-7.","journal-title":"Nat Metab"},{"issue":"2","key":"172_CR142","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2337\/db10-0801","volume":"60","author":"CK Tan","year":"2011","unstructured":"Tan CK, Leuenberger N, Tan MJ, Yan YW, Chen Y, Kambadur R, Wahli W, Tan NS. Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet. Diabetes. 2011;60(2):464\u201376. https:\/\/doi.org\/10.2337\/db10-0801.","journal-title":"Diabetes"},{"issue":"3","key":"172_CR141","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1038\/nutd.2012.1","volume":"2","author":"CK Tan","year":"2012","unstructured":"Tan CK, Chong HC, Tan EH, Tan NS. Getting \u2018smad\u2019 about obesity and diabetes. Nutr Diabetes. 2012;2(3):e29. https:\/\/doi.org\/10.1038\/nutd.2012.1.","journal-title":"Nutr Diabetes"},{"issue":"4","key":"172_CR143","doi-asserted-by":"publisher","first-page":"101748","DOI":"10.1016\/j.jbc.2022.101748","volume":"298","author":"S Toyoda","year":"2022","unstructured":"Toyoda S, Shin J, Fukuhara A, Otsuki M, Shimomura I. Transforming growth factor beta1 signaling links extracellular matrix remodeling to intracellular lipogenesis upon physiological feeding events. J Biol Chem. 2022;298(4):101748. https:\/\/doi.org\/10.1016\/j.jbc.2022.101748.","journal-title":"J Biol Chem"},{"issue":"12","key":"172_CR144","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41401-019-0264-2","volume":"40","author":"WZ Tu","year":"2019","unstructured":"Tu WZ, Fu YB, Xie X. RepSox, a small molecule inhibitor of the TGFbeta receptor, induces brown adipogenesis and Browning of white adipocytes. Acta Pharmacol Sin. 2019;40(12):1523\u201331. https:\/\/doi.org\/10.1038\/s41401-019-0264-2.","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"172_CR145","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41569-023-00847-5","volume":"20","author":"PL Valenzuela","year":"2023","unstructured":"Valenzuela PL, Carrera-Bastos P, Castillo-Garcia A, Lieberman DE, Santos-Lozano A, Lucia A. Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol. 2023;20(7):475\u201394. https:\/\/doi.org\/10.1038\/s41569-023-00847-5.","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"172_CR146","doi-asserted-by":"publisher","first-page":"e77221","DOI":"10.1371\/journal.pone.0077221","volume":"8","author":"GH Vijgen","year":"2013","unstructured":"Vijgen GH, Bouvy ND, Leenen L, Rijkers K, Cornips E, Majoie M, Brans B, van Lichtenbelt M, W. D. Vagus nerve stimulation increases energy expenditure: relation to brown adipose tissue activity. PLoS ONE. 2013;8(10):e77221. https:\/\/doi.org\/10.1371\/journal.pone.0077221.","journal-title":"PLoS ONE"},{"issue":"2","key":"172_CR147","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/JOE-19-0295","volume":"243","author":"J Villarroya","year":"2019","unstructured":"Villarroya J, Cereijo R, Gavalda-Navarro A, Peyrou M, Giralt M, Villarroya F. New insights into the secretory functions of brown adipose tissue. J Endocrinol. 2019;243(2):R19\u201327. https:\/\/doi.org\/10.1530\/JOE-19-0295.","journal-title":"J Endocrinol"},{"issue":"2","key":"172_CR148","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.seizure.2004.11.001","volume":"14","author":"K Vonck","year":"2005","unstructured":"Vonck K, Dedeurwaerdere S, De Groote L, Thadani V, Claeys P, Gossiaux F, Van Roost D, Boon P. Generator replacement in epilepsy patients treated with vagus nerve stimulation. Seizure. 2005;14(2):89\u201399. https:\/\/doi.org\/10.1016\/j.seizure.2004.11.001.","journal-title":"Seizure"},{"issue":"7540","key":"172_CR149","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, Quinn MC, Robertson AJ, Fadlullah MZ, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Grimmond SM. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518(7540):495\u2013501. https:\/\/doi.org\/10.1038\/nature14169.","journal-title":"Nature"},{"issue":"6","key":"172_CR154","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/CIRCHEARTFAILURE.114.001564","volume":"7","author":"Z Wang","year":"2014","unstructured":"Wang Z, Yu L, Wang S, Huang B, Liao K, Saren G, Tan T, Jiang H. Chronic intermittent low-level transcutaneous electrical stimulation of auricular branch of vagus nerve improves left ventricular remodeling in conscious dogs with healed myocardial infarction. Circ Heart Fail. 2014;7(6):1014\u201321. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001564.","journal-title":"Circ Heart Fail"},{"issue":"7818","key":"172_CR153","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41586-020-2527-y","volume":"583","author":"P Wang","year":"2020","unstructured":"Wang P, Loh KH, Wu M, Morgan DA, Schneeberger M, Yu X, Chi J, Kosse C, Kim D, Rahmouni K, Cohen P, Friedman J. A leptin-BDNF pathway regulating sympathetic innervation of adipose tissue. Nature. 2020;583(7818):839\u201344. https:\/\/doi.org\/10.1038\/s41586-020-2527-y.","journal-title":"Nature"},{"issue":"2","key":"172_CR151","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41419-021-03488-z","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Wang P, Xu M, Song X, Wu H, Evert M, Calvisi DF, Zeng Y, Chen X. Distinct functions of transforming growth factor-beta signaling in c-MYC driven hepatocellular carcinoma initiation and progression. Cell Death Dis. 2021;12(2):200. https:\/\/doi.org\/10.1038\/s41419-021-03488-z.","journal-title":"Cell Death Dis"},{"issue":"1","key":"172_CR152","doi-asserted-by":"publisher","first-page":"379","DOI":"10.7150\/thno.67034","volume":"12","author":"HL Wang","year":"2022","unstructured":"Wang HL, Wei B, He HJ, Huang XR, Sheng JY, Chen XC, Wang L, Tan RZ, Li JC, Liu J, Yang SJ, Ma RC, Lan HY. Smad3 deficiency improves islet-based therapy for diabetes and diabetic kidney injury by promoting beta cell proliferation via the E2F3-dependent mechanism. Theranostics. 2022;12(1):379\u201395. https:\/\/doi.org\/10.7150\/thno.67034.","journal-title":"Theranostics"},{"issue":"7968","key":"172_CR150","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-023-06249-4","volume":"619","author":"D Wang","year":"2023","unstructured":"Wang D, Townsend LK, DesOrmeaux GJ, Frangos SM, Batchuluun B, Dumont L, Kuhre RE, Ahmadi E, Hu S, Rebalka IA, Gautam J, Jabile MJT, Pileggi CA, Rehal S, Desjardins EM, Tsakiridis EE, Lally JSV, Juracic ES, Tupling AR, Steinberg GR. GDF15 promotes weight loss by enhancing energy expenditure in muscle. Nature. 2023;619(7968):143\u201350. https:\/\/doi.org\/10.1038\/s41586-023-06249-4.","journal-title":"Nature"},{"key":"172_CR155","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.molmet.2018.07.008","volume":"16","author":"UD Wankhade","year":"2018","unstructured":"Wankhade UD, Lee JH, Dagur PK, Yadav H, Shen M, Chen W, Kulkarni AB, McCoy JP, Finkel T, Cypess AM, Rane SG. TGF-beta receptor 1 regulates progenitors that promote Browning of white fat. Mol Metab. 2018;16:160\u201371. https:\/\/doi.org\/10.1016\/j.molmet.2018.07.008.","journal-title":"Mol Metab"},{"issue":"13","key":"172_CR156","doi-asserted-by":"publisher","first-page":"108550","DOI":"10.1016\/j.celrep.2020.108550","volume":"33","author":"AK Wara","year":"2020","unstructured":"Wara AK, Wang S, Wu C, Fang F, Haemmig S, Weber BN, Aydogan CO, Tesmenitsky Y, Aliakbarian H, Hawse JR, Subramaniam M, Zhao L, Sage PT, Tavakkoli A, Garza A, Lynch L, Banks AS, Feinberg MW. KLF10 deficiency in CD4(+) T cells triggers obesity, insulin resistance, and fatty liver. Cell Rep. 2020;33(13):108550. https:\/\/doi.org\/10.1016\/j.celrep.2020.108550.","journal-title":"Cell Rep"},{"issue":"1","key":"172_CR157","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-022-01149-x","volume":"7","author":"X Wen","year":"2022","unstructured":"Wen X, Zhang B, Wu B, Xiao H, Li Z, Li R, Xu X, Li T. Signaling pathways in obesity: mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022;7(1):298. https:\/\/doi.org\/10.1038\/s41392-022-01149-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"172_CR158","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa2302392","volume":"389","author":"S Wharton","year":"2023","unstructured":"Wharton S, Blevins T, Connery L, Rosenstock J, Raha S, Liu R, Ma X, Mather KJ, Haupt A, Robins D, Pratt E, Kazda C, Konig M, Investigators G. Daily oral GLP-1 receptor agonist Orforglipron for adults with obesity. N Engl J Med. 2023;389(10):877\u201388. https:\/\/doi.org\/10.1056\/NEJMoa2302392.","journal-title":"N Engl J Med"},{"key":"172_CR159","unstructured":"WHO. (2018). Obesity and overweight. Retrieved September 1 from https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"issue":"11","key":"172_CR160","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF, Group SS. Once-Weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989\u20131002. https:\/\/doi.org\/10.1056\/NEJMoa2032183.","journal-title":"N Engl J Med"},{"issue":"8","key":"172_CR161","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.14725","volume":"24","author":"JPH Wilding","year":"2022","unstructured":"Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF, Group SS. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553\u201364. https:\/\/doi.org\/10.1111\/dom.14725.","journal-title":"Diabetes Obes Metab"},{"issue":"6488","key":"172_CR162","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/370341a0","volume":"370","author":"JL Wrana","year":"1994","unstructured":"Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-beta receptor. Nature. 1994;370(6488):341\u20137. https:\/\/doi.org\/10.1038\/370341a0.","journal-title":"Nature"},{"issue":"3","key":"172_CR163","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/21623945.2018.1493901","volume":"7","author":"S Wueest","year":"2018","unstructured":"Wueest S, Konrad D. The role of adipocyte-specific IL-6-type cytokine signaling in FFA and leptin release. Adipocyte. 2018;7(3):226\u20138. https:\/\/doi.org\/10.1080\/21623945.2018.1493901.","journal-title":"Adipocyte"},{"issue":"1","key":"172_CR164","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/db08-0392","volume":"58","author":"J Xu","year":"2009","unstructured":"Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R, Li YS, Lindberg RA, Chen JL, Jung DY, Zhang Z, Ko HJ, Kim JK, Veniant MM. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 2009;58(1):250\u20139. https:\/\/doi.org\/10.2337\/db08-0392.","journal-title":"Diabetes"},{"key":"172_CR165","doi-asserted-by":"publisher","unstructured":"Xu J, Ma H, Liu Y. Stochastic optical reconstruction microscopy (STORM). Curr Protoc Cytom. 2017;81. https:\/\/doi.org\/10.1002\/cpcy.23. 46 11\u201312 46 27.","DOI":"10.1002\/cpcy.23"},{"issue":"1","key":"172_CR166","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cmet.2011.04.013","volume":"14","author":"H Yadav","year":"2011","unstructured":"Yadav H, Quijano C, Kamaraju AK, Gavrilova O, Malek R, Chen W, Zerfas P, Zhigang D, Wright EC, Stuelten C, Sun P, Lonning S, Skarulis M, Sumner AE, Finkel T, Rane SG. Protection from obesity and diabetes by Blockade of TGF-beta\/Smad3 signaling. Cell Metab. 2011;14(1):67\u201379. https:\/\/doi.org\/10.1016\/j.cmet.2011.04.013.","journal-title":"Cell Metab"},{"issue":"9","key":"172_CR167","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nm.3616","volume":"20","author":"J Yan","year":"2014","unstructured":"Yan J, Zhang H, Yin Y, Li J, Tang Y, Purkayastha S, Li L, Cai D. Obesity- and aging-induced excess of central transforming growth factor-beta potentiates diabetic development via an RNA stress response. Nat Med. 2014;20(9):1001\u20138. https:\/\/doi.org\/10.1038\/nm.3616.","journal-title":"Nat Med"},{"issue":"2","key":"172_CR169","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/hep.26698","volume":"59","author":"L Yang","year":"2014","unstructured":"Yang L, Roh YS, Song J, Zhang B, Liu C, Loomba R, Seki E. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology. 2014;59(2):483\u201395. https:\/\/doi.org\/10.1002\/hep.26698.","journal-title":"Hepatology"},{"issue":"10","key":"172_CR168","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang L, Chang CC, Sun Z, Madsen D, Zhu H, Padkjaer SB, Wu X, Huang T, Hultman K, Paulsen SJ, Wang J, Bugge A, Frantzen JB, Norgaard P, Jeppesen JF, Yang Z, Secher A, Chen H, Li X, Jorgensen SB. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017;23(10):1158\u201366. https:\/\/doi.org\/10.1038\/nm.4394.","journal-title":"Nat Med"},{"issue":"9","key":"172_CR170","doi-asserted-by":"publisher","first-page":"114676","DOI":"10.1016\/j.celrep.2024.114676","volume":"43","author":"X Yang","year":"2024","unstructured":"Yang X, Bhowmick K, Rao S, Xiang X, Ohshiro K, Amdur RL, Hassan MI, Mohammad T, Crandall K, Cifani P, Shetty K, Lyons SK, Merrill JR, Vegesna AK, John S, Latham PS, Crawford JM, Mishra B, Dasarathy S, Mishra L. Aldehydes alter TGF-beta signaling and induce obesity and cancer. Cell Rep. 2024;43(9):114676. https:\/\/doi.org\/10.1016\/j.celrep.2024.114676.","journal-title":"Cell Rep"},{"key":"172_CR177","doi-asserted-by":"publisher","unstructured":"Yao G, Kang L, Li J, Long Y, Wei H, Ferreira CA, Jeffery JJ, Lin Y, Cai W, Wang X. Effective weight control via an implanted self-powered vagus nerve stimulation device. Nat Commun. 2018;9(1):5349. https:\/\/doi.org\/10.1038\/s41467-018-07764-z.","DOI":"10.1038\/s41467-018-07764-z"},{"issue":"4","key":"172_CR171","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bbadis.2010.01.006","volume":"1802","author":"CX Yi","year":"2010","unstructured":"Yi CX, la Fleur SE, Fliers E, Kalsbeek A. The role of the autonomic nervous liver innervation in the control of energy metabolism. Biochim Biophys Acta. 2010;1802(4):416\u201331. https:\/\/doi.org\/10.1016\/j.bbadis.2010.01.006.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"172_CR172","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.2337\/db10-0013","volume":"59","author":"LE Zaragosi","year":"2010","unstructured":"Zaragosi LE, Wdziekonski B, Villageois P, Keophiphath M, Maumus M, Tchkonia T, Bourlier V, Mohsen-Kanson T, Ladoux A, Elabd C, Scheideler M, Trajanoski Z, Takashima Y, Amri EZ, Lacasa D, Sengenes C, Ailhaud G, Clement K, Bouloumie A, Dani C. Activin a plays a critical role in proliferation and differentiation of human adipose progenitors. Diabetes. 2010;59(10):2513\u201321. https:\/\/doi.org\/10.2337\/db10-0013.","journal-title":"Diabetes"},{"issue":"6","key":"172_CR173","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/hep4.1892","volume":"6","author":"J Zhao","year":"2022","unstructured":"Zhao J, Hu L, Gui W, Xiao L, Wang W, Xia J, Fan H, Li Z, Zhu Q, Hou X, Chu H, Seki E, Yang L. Hepatocyte TGF-beta signaling inhibiting WAT Browning to promote NAFLD and obesity is associated with Let-7b-5p. Hepatol Commun. 2022;6(6):1301\u201321. https:\/\/doi.org\/10.1002\/hep4.1892.","journal-title":"Hepatol Commun"},{"key":"172_CR174","doi-asserted-by":"publisher","unstructured":"Zhao M, Okunishi K, Bu Y, Kikuchi O, Wang H, Kitamura T, Izumi T. Targeting activin receptor-like kinase 7 ameliorates adiposity and associated metabolic disorders. JCI Insight. 2023;8(4). https:\/\/doi.org\/10.1172\/jci.insight.161229.","DOI":"10.1172\/jci.insight.161229"},{"issue":"10","key":"172_CR176","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/hep4.1108","volume":"1","author":"M Zhou","year":"2017","unstructured":"Zhou M, Learned RM, Rossi SJ, DePaoli AM, Tian H, Ling L. Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice. Hepatol Commun. 2017;1(10):1024\u201342. https:\/\/doi.org\/10.1002\/hep4.1108.","journal-title":"Hepatol Commun"},{"issue":"1","key":"172_CR175","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10020-020-00195-x","volume":"26","author":"M Zhou","year":"2020","unstructured":"Zhou M, Aziz M, Ochani M, Wang P. Correction of immunosuppression in aged septic rats by human Ghrelin and growth hormone through the vagus nerve-dependent Inhibition of TGF-beta production. Mol Med. 2020;26(1):71. https:\/\/doi.org\/10.1186\/s10020-020-00195-x.","journal-title":"Mol Med"}],"container-title":["Bioelectronic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42234-025-00172-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42234-025-00172-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42234-025-00172-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T23:03:39Z","timestamp":1745967819000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioelecmed.biomedcentral.com\/articles\/10.1186\/s42234-025-00172-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":178,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["172"],"URL":"https:\/\/doi.org\/10.1186\/s42234-025-00172-x","relation":{},"ISSN":["2332-8886"],"issn-type":[{"value":"2332-8886","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants were informed and gave written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}